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Abstract
Two polymorphisms in the IL4 (G/C 3 -UTR) and IL5 (C-703T) genes were studied in
a sample of families whose probands had atopic bronchial asthma (BA) (66 families,
n = 183) and in a group of non-cognate individuals with the severe form of the disease
(n = 34). The samples were collected from the Russian population in the city of Tomsk
(Russia). Using the transmission/disequilibrium test (TDT), a signiﬁcant association
of allele C-703 IL5 with BA was established (TDT = 4.923, p = 0.007 ± 0.0007). The
analysis of 40 individuals with mild asthma and 49 patients with the severe form
of the disease revealed a negative association of genotype GG IL4 (OR = 0.39, 95%
CI = 0.15–0.99, p = 0.035), and also a trend towards a positive association of the
GC IL4 genotype (OR = 2.52, 95% CI = 0.98–6.57, p = 0.052) with mild BA. There
was a concordance of the clinical classiﬁcation of BA severity with the ‘genotype’
(McNemar’s X2 test with continuity correction constituted 0.03, d.f. = 1, p = 0.859).
These results suggest that polymorphisms in the IL4 and IL5 genes contribute to the
susceptibility to atopic BA and could determine the clinical course of the disease.
Copyright  2003 John Wiley & Sons, Ltd.
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Introduction
Atopic bronchial asthma (BA) is a widespread
allergy-mediated inﬂammatory disease of the res-
piratory tract. From a genetic point of view it is
a complex disease whose aetiology and pathogen-
esis are determined by the interaction of numer-
ous hereditary and environmental factors. Multiple
studies carried out during the last 10–15 years have
resulted in signiﬁcant progress in the understanding
of the molecular–genetic basis for the predispo-
sition to the disease. Several successful genome-
wide screenings have been carried out. About 10
chromosomal loci with signiﬁcant linkage to the
asthma phenotype have been repeatedly reported.
Polymorphisms of about 50 candidate genes have
been investigated. Experiments on cell lines and
model organisms have been conducted (Cookson
and Moffatt, 2000). In comparison with other com-
plex diseases, there is probably a better coincidence
for BA in genetic data obtained by different
scientiﬁc groups.
However, genetic susceptibility to BA is still
far from being completely understood. Partially,
this is because many candidate genes that could
potentially contribute to the susceptibility to the
disease have not been investigated to date, and not
all of the polymorphisms of the candidate genes
have been tested for a possible association with the
disorder. These circumstances make it necessary
to examine new polymorphisms of BA candidate
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genes regarding their contribution to the disease
and to its clinical manifestation.
The human IL4 and IL5 genes, encoding inter-
leukin-4 and interleukin-5, respectively, are strong
candidates for BA because these cytokines are the
key molecules for such pathogenetic components
of the disease as allergy and eosinophilic inﬂam-
mation. Both genes are located on chromosome
5q31–33, a region well-known to be in signiﬁcant
linkage with BA and disease associated traits such
as serum IgE levels and bronchial hyperrespon-
siveness. Single nucleotide polymorphisms in the
IL4 and IL5 genes have recently been described:
a G to C transversion in the 3 -untranslated region
(3 -UTR) of the IL4 gene at nucleotide 9291 was
found at the Experimental Medicine Unit (headed
by Professor Julian M. Hopkin) of the University of
Wales, Swansea, UK (T. Shirakawa, personal com-
munication), and a C to T transition at nucleotide
703 upstream of the ﬁrst ATG codon of the IL5
gene (C-703T) was found in the genetic analysis
of familial eosinophilia (Rioux et al., 1997). Both
polymorphisms are located outside of the known
control regions of the genes. As far as we are
aware, these polymorphisms have not yet been
tested for association with BA.
In the present study, an association analysis of
BA, and its severity, with the G/C 3 -UTR IL4 and
the C-703T IL5 polymorphisms has been carried




In total, 66 families (n = 183) with a child affected
by BA were studied. They were interviewed and
consent to participate in the study was obtained.
The age range of the probands (children with
BA) was 1.5–15 years (mean age ± SD consti-
tuted 8.4 ± 3.4 years). The majority of probands
were boys (n = 46). The results of physical exam-
ination and medical history were collected from
51 trios (two parents and an affected child) and
15 incomplete families (one parent was absent).
WHO criteria were used to deﬁne the bronchial
asthma phenotype in all affected subjects exam-
ined in this study (National Heart, Lung and Blood
Institute, 1995). Additionally, 34 unrelated patients
(16 males, 18 females, mean age ± SD consti-
tuted 39.4 ± 4.4 years) with a diagnosis of severe
atopic BA, based on the same clinical criteria, were
included in the study. All individuals were of Rus-
sian ethnicity and lived permanently in Tomsk.
Genotyping
Genotypes were determined by restriction analy-
ses of PCR products using techniques developed in
the Experimental Medicine Unit at the University
of Wales Swansea. For genotyping of the G/C 3 -
UTR polymorphism in the IL4 gene the following
oligonucleotide primers were used: 5 -ctc-agt-aca-
cca-tat-ggc-t (nucleotides 9028–9046, according to
the published sequence of the human IL4 gene;
GenBank ID, M23442) and 5 -cca-gtg-act-atc-att-
ata-att-cc (nucleotides 9628–9606). The PCR mix-
ture contained 2.5 pmol speciﬁed primers, 2 mmol
each dNTP, 1.2 µl1 0 × reaction buffer, 1.5 mM
MgCl2,0 . 5UTaq DNA-polymerase (‘SibEnzyme’,
Russia), and 100–200 ng genomic DNA. PCR con-
ditions were as follows: initial denaturation at 94 ◦C
for 5 min, followed by 33 cycles of annealing at
60 ◦C (1 min); elongation at 72 ◦C (45 s); denatura-
tion at 94 ◦C (45 s); and a ﬁnal elongation at 72 ◦C
for 8 min. PCR-products were cleaved overnight
with 5 U VneI (isoschizomer of ApaLI; ‘SibEn-
zyme’, Russia), and the resulting fragments were
resolved on a 2% agarose gel stained with ethidium
bromide and visualized under UV light. Homozy-
gotes for allele G were recognized by the presence
of two bands of 332 bp and 269 bp, homozygotes
for allele C had a single 601 bp band, and heterozy-
gotes had all three bands.
For the genotyping of the C-703T transition in
the IL5 gene the following oligonucleotide primers
were used: 5 -cag-gga-gag-cca-atc-agt (nucleotides
−857 to −840 according to the published sequence
of the human IL5 gene; GenBank ID, J03478) and
5 -atg-atg-tcc-aga-ctc-cag-gat-ct (nucleotides −680
to −702; the underlined base is exchanged to incor-
porate a restriction site for AlwNI in the case of
allele C). The PCR mixture and the program for
ampliﬁcation were similar to those for G/C 3 -UTR
IL4. The PCR products were cleaved overnight
with 0.013 U AlwNI (New England Biolabs, USA).
The products of hydrolysis were resolved on a
3% agarose gel stained with ethidium bromide and
visualized under UV light. Homozygotes for allele
C were recognized by the presence of two bands
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of 160 bp and 18 bp, homozygotes for allele T had
a single 178 bp band, and heterozygotes had all
three bands.
Association analysis
The analysis of association of genetic polymor-
phisms with BA was carried out by TDT (Spiel-
man et al., 1993). In this test, the numbers of
allele transmissions from heterozygous parents to
their affected offspring are used to estimate degrees
of association. For the evaluation of the signiﬁ-
cance level for TDT, a Monte Carlo-based pro-
cedure was applied, with a 15000 pseudosam-
ple simulation, using the program Nx23 by Yuri
Aulchenko (Institute of Cytology and Genetics,
Novosibirsk, Russia).
Results and discussion
In this study, a total of 114 cases of IL4 trans-
mission and 113 cases of IL5 transmission were
accounted for out of 117 possible cases, for 51
couples and 15 single parents. We failed to deter-
mine which allele was transmitted in three cases
for IL4 and in four cases for IL5 because of
the heterozygosity of single parents and their chil-
dren.
For the G/C 3 -UTR polymorphism of the IL4
gene, 48 cases of alleles transmitted from het-
erozygous parents to their affected children were
revealed: 21 for allele G and 27 for allele C
(Table 1). The deviation from equal segregation
was non-signiﬁcant (TDT = 0.750, p = 0.476 ±
0.0041). For the C-703T polymorphism of the
IL5 gene, 52 cases of alleles transmitted from
heterozygous parents to their affected children
were revealed: 34 for allele C and 18 for allele
T (Table 1). This distribution deviated signiﬁ-
cantly from equal segregation (TDT = 4.923, p =
0.007 ± 0.0007).
These data suggest a signiﬁcant association of
the C-703 allele of the IL5 gene with atopic BA
in Russians. Since the C-703T transition is located
in the promoter region of IL5 it could affect the
expression of the gene and, hence, inﬂuence the
level of interleukin-5. The important role of this
cytokine in BA pathogenesis was determined by
its ability to activate eosinophils, which in turn
participate in the development and prolongation of
airway inﬂammation (Chung and Barnes, 1999).
Taking into account that the association with BA
was found for the C-703 allele, it could be assumed
that this variant of the gene was expressed at a
higher level in comparison with that of the T-
703 allele and caused an increased production of
interleukin-5, predisposing to BA.
There was no prior evidence for an association
of IL5 common polymorphisms with BA. The
analyses of sequences of IL5 and IL5RA (encoding
an α-chain of the interleukin-5 receptor) genes in
a sample of 30 patients with BA and 30 healthy
individuals did not reveal any variants, and it
was concluded that polymorphisms of these genes
were unlikely to contribute to the BA phenotype
(Pereira et al., 1998). Analysis of the association
of the transition C-703T in IL5 with familial
eosinophilia also yielded negative results (Rioux
et al., 1998). Thus, the association of C-703T with
asthma in Russians provides the ﬁrst evidence for
a possible contribution of common polymorphism
in the IL5 gene with a complex pathological
Table 1. Distribution of alleles of the IL4 and IL5 genes, transmitted to probands with atopic bronchial asthma from their
heterozygous parents
Number of alleles, transmitted
to affected offspring from
heterozygous parents
Gene Polymorphism Observed Expected TDT∗ p∗∗
IL4 G/C 3 -UTR G: 21 24 0.750 0.474 ± 0.0041
C: 27 24
IL5 C-703T C: 34 26 4.923 0.007 ± 0.0007
T: 18 26
∗ Transmission/disequilibrium test statistics (Spielman et al., 1993).
∗∗ Signiﬁcance level for TDT (Monte Carlo-based approach; 15000 simulations were used).
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condition, the manifestation of which strongly
depends on eosinophil expansion.
In addition to the analysis of the association
of the polymorphisms in the IL4 and IL5 genes
with BA, their association with the severity of the
disease was also evaluated. For this purpose, 55
unrelated patients with mild and severe BA were
randomly chosen from the family sample. In addi-
tion, 34 unrelated patients with the severe form of
the disease were included. The sample analysed
contained 40 patients with mild BA and 49 with
severe BA.
By comparison of genotype frequencies, a sig-
niﬁcant negative association of genotypes GG IL4
(OR = 0.39, 95% CI = 0.15–0.99, p = 0.035) and
TT IL5 (OR = 0.00; 95% CI = 0.00–1.09, p =
0.031) with mild asthma was found (Table 2). Fur-
thermore, a trend to a positive association of the
genotype GC IL4 with mild BA (OR = 2.52, 95%
CI = 0.98–6.57, p = 0.052) and a non-signiﬁcant
prevalence of the allele G IL4 in patients with
severe forms of the disease in comparison with that
in individuals with mild asthma (OR = 0.53, 95%
CI = 0.26–1.11, p = 0.085) were observed.
These data suggest that genotype GG IL4 is a
risk factor for the severe course of atopic BA. Tak-
ing into account the association of allele C-703
of IL5 with BA, the signiﬁcant prevalence of the
genotype TT IL5 in patients with severe asthma in
comparison to those with mild forms of the dis-
order appears quite paradoxical: it is difﬁcult to
understand why one allele would contribute to the
disease, whereas the alternative allele would pro-
voke its severe course. In the samples investigated,
four individuals with the genotype GG IL4 had
also the genotype TT IL5 (about 67%). Hence, it
is conceivable that the observed association of the
genotype TT IL5 with severe BA is accidental.
Interleukin-4 is the key cytokine in allergic
responses. It induces differentiation of CD4+ T-
lymphocytes to Th2-helper cells, and accounts
for immunoglobulin heavy chain µ to ε isotype
switching, thus resulting in IgE synthesis (Paul
and Seder, 1994; Stavnezer, 1996). An ampli-
ﬁcation of interleukin-4 production is the main
stimulus for the increase and prolongation of IgE
synthesis in patients with atopic diseases (Chung
and Barnes, 1999). Probably, interleukin-4 hyper-
production also can cause the severe course of
BA. The transversion of nucleotide G to C that
we have studied is located outside of the cod-
ing region of the IL4 gene, therefore it could
inﬂuence the gene expression proﬁle. The near-
est control elements to the G/C polymorphism in
the IL4 gene are the transcriptional stop-codon
TAA (nucleotides 8676–8678) and the polyA sig-
nal AATAAA (nucleotides 9639–9644), but it is
not known to date whether the G/C polymor-
phism we have studied inﬂuences the functioning
of these elements.
The results presented may be of interest for pre-
diction on the prognosis of disease manifestation.
If a genotype is expected to contribute to a speciﬁc
clinical phenotype, one might be able to predict
the probability of its realization and to choose the
Table 2. Number and percentage (in parentheses) of genotypes and allelic frequencies (±SE) of the IL4 and IL5 gene
polymorphisms in patients with different severities of atopic bronchial asthma (BA)
Severity of BA
Gene Polymorphism Mild Severe OR (95% CI)∗ p∗
IL4 G/C 3 -UTR GG 16 (40.0) 31 (63.3) 0.39 (0.15–0.99) 0.035
GC 22 (55.0) 16 (32.6) 2.52 (0.98–6.57) 0.052
CC 2 (5.0) 2 (4.1) 1.24 (0.12–13.06) 0.999
G0 .675 ± 0.052 0.796 ± 0.410 0.53 (0.26–1.11) 0.085
IL5 C-703T CC 25 (62.5) 26 (53.1) 1.47 (0.58–3.78) 0.397
CT 15 (37.5) 17 (34.7) 1.13 (0.43–2.95) 0.827
TT 0 (0.00) 6 (12.2) 0.00 (0.00–1.09) 0.031
C0 .813 ± 0.044 0.704 ± 0.046 1.82 (0.85–3.94) 0.117
∗ Odds ratio with 95% conﬁdential interval (in parentheses) of mild BA in comparison with the severe form of the disorder in probands with
designated genotype or allele.
∗∗ Signiﬁcance level by two-tailed Fisher’s exact test.
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appropriate therapy. To check the prognostic value
of the G/C 3 -UTR polymorphism in the IL4 gene
in relation to BA severity, a ‘genotype’ diagno-
sis was stated for unrelated individuals: the severe
form of the disease was applied to men with the GG
genotype, and mild BA form was applied to those
with the GC genotype. Four homozygotes for the
allele C IL4 were excluded as non-informative, so
85 subjects in total were included in the sample. In
this group, an estimate of correspondence between
‘genotype’ classiﬁcation and clinical diagnosis was
carried out. The analysis of the contingency table
revealed a successful conformity of the diagnostic
approaches: McNemar’s X2 with continuity correc-
tion constituted 0.03, d.f. = 1, p = 0.859 (Table 3).
Coincidence of diagnoses was obtained in 53 cases
out of 85 (62.4%). Thus, we wish to propose that
the G/C 3 -UTR polymorphism in the IL4 gene
might serve a prognostic purpose for BA sever-
ity. However, it can be used only as an additional
predictive criterion, because its use as a marker of
severe or mild BA course failed in 37.6% of cases.
In the present study, two common polymor-
phisms in the regulatory regions of the IL4 and
IL5 genes were analysed. These genes have been
reported as the candidate genes of atopic BA, and
Table 3. Distribution of individuals with different severity
of bronchial asthma by clinical and ‘genotype’ diagnosis∗
Clinical diagnosis
‘Genotype’ diagnosis Severe asthma Mild asthma
Severe asthma 31 16
Mild asthma 16 22
∗ The ‘genotype’ diagnosis was stated by G/C 3 -UTR IL4
polymorphism: the severe form of the disease was applied to
individuals with genotype GG IL4, and the mild form was applied
to those with genotype GC IL4. Homozygotes on allele C IL4
were excluded as non-informative. Differences between clinical
and ‘genotype’ diagnoses are non-signiﬁcant: McNemar’s X2 with
continuity correction constituted 0.03, d.f. = 1, p = 0.859.
their protein products are the key molecules for
such pathogenetic components of the disease as
allergy and eosinophilic inﬂammation. The C-703T
polymorphism in the IL5 gene is associated with
BA (allele C) and the G/C 3 -UTR polymorphism
in the IL4 gene is associated with the severe form
of the disease. To date, there are no functional
data on these polymorphisms, therefore the mech-
anisms of their association with BA are presently
unknown. To clarify these mechanisms it will be
necessary to design transgenic cell lines to esti-
mate the expression levels of the genes depending
on their genotypes at these polymorphic sites.
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